Genetic-Associated Reduced Efficiency and Safety of Cohort Immunization

M.V. Supotnitskyi

Abstract


Low efficiency of cohort immunization and postvaccinal complication are not always connected with vaccine unsatisfactory quality or violation of vaccination requirements by medical workers. The paper demonstrates that epidemic dynamics, disease clinical manifestation typical for it, efficiency and safety of immunization, postvaccinal complications incidence also closely interrelate with relative quantity of persons with anomalies (polymorphism) of immune response genes and physiologic systems protected from disease development. Polymorphism of these genes has a spontaneous development by single nucleotide polymorphism and deletions forming apportioning in next generations according to Mendel’s laws. Polymorphism accumulation involved into infectious diseases pathogenesis is ironically a result of progress in control of contagious cycle infections, particularly natural smallpox. There was taken off a selective pressure from a population that extracted persons unable to react effectively on infectious agents invasion. Velocity of polymorphism accumulation is growing in relatively genetically homogeneous population (inhabitants of island countries) and in populations with typical intermarriages. It is impossible to refuse from control of contagious infectious agents. So we should expect of increase of registered postvaccinal complication associated rather with human genome peculiarity than with other reasons. That causes the necessity to adjust a strategy of immunization of various cohorts and methods for determining the reasons of postvaccinal complications. The paper also describes polymorphism of immune response genes significantly associated with low effectiveness of vaccination against measles, rubella, epidemic parotitis, B hepatitis and complications after live smallpox and tuberculosis vaccine Mycobacterium bovis BCG.


References


Ясинский А.А., Михеева И.В. Безопасность иммунизации // Вакцины и вакцинация. Национальное руководство / Зверев В.В., Семенов Б.Ф., Хаитов Р.М. — М., 2011. — С. 137-61.

Blackwell J.M., Jamieson S.F., Burgner D. HLA and Infectious Diseases // Clinical Microbiology Reviews. — 2009. — № 22(2). — Р. 370-85.

Петухов В.Л., Жигачев А.И., Назарова Г.А. Ветеринарная генетика. — М., 1996.

Hill A. Genetics of infectious disease // Phil. Trans. R. Soc. B. — 2012 — № 367. — Р. 840-9.

Губерт В.О. Оспа и оспопрививание. — СПб., 1896.

Downie A.W., McCarthy K. The antibody response in man following infection with viruses of the pox group. III. Antibody response in smallpox // J. Hyg. (London). — 1958. — № 56. — Р. 479-87.

Rumyantsev S.N. The origin of individual differences in the course and severity of diseases // The Sci. World J. — 2006. — № 6. — Р. 1674-704.

Poland G.A., Ovsyannikova I.G., Jacobson R.M. Vaccine immunogenetics: bedside to bench to population // Vaccine. — 2008. — № 26(49). — Р. 6183-8.

Marquet S., Schurr E. Genetics of susceptibility to infectious diseases: tuberculosis and leprosy as examples // Drug Metabolism and Disposition. — 2001. — № 29(4). — Р. 478-83.

Rasmussen A.L., Okumura A., Ferris M.T., Green R., Feldmann F., Kelly S.M. et al. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance // Science. — 2014. — № 346(6212). — Р. 987-91.

Blackwell J.M., Jamieson S.F., Burgner D. HLA and Infectious Diseases // Clinical Microbiology Reviews. — 2009. — № 22(2). — Р. 370-85.

Галактионов В.Г. Иммунология. — М., 1998.

Коротяев А.И., Бабичев С.А. Медицинская микробиология, иммунология и вирусология. — СПб., 1998.

Короткова И.Ю. Клиническая иммуногенетика заболеваний, злокачественных новообразований и хронических воспалительных процессов: Автореф. дис… д-ра мед. наук. — Новосибирск, 2007.

Бухарин О.В., Усвяцов Б.Я. Бактерионосительство. — Екатеринбург, 1996.

Singh N., Agrawal S., Rastogi A. Infectious diseases and immunity: Special reference to major histocompatability complex // Emerging Infectious Diseases. — 1997. — № 3(1). — Р. 24-34.

Helbig K., Harris R., Ayres J., Dunckley H., Lloyd A., Robson J., Marmion B.P. Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever // Q.J. Med. — 2005. — № 98. — Р. 565-74.

Hill A., Elvin J., Will A., Aidoo M., Allsopp C.E., Gotch F.M. et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria // Nature. — 1992. — № 360. — Р. 434-9.

Hill A. Genetics and genomics of infectious disease susceptibility // British Medical Bulletin. — 1999. — № 55(2). — Р. 401-13.

Wilson A., Symons J., McDowell T., McDevitt H.O., Duff G.W. Effects of polymorphism in the tumor necrosis factor alpha promoter on transcriptional activation // Proc. Natl. Acad. Sci. USA. — 1997. — № 94(10). — Р. 3195-9.

Kalish R.A., Leong J.M., Steere A.C. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi // Infect. Immun. — 1993. — № 61(7). — Р. 2774-9.

Fitness J., Tosh K., Hill A. Genetics of susceptibility to leprosy // Genes and Immunity. — 2002. — № 3. — Р. 441-53.

Singh N., Agrawal S., Rastogi A. Infectious diseases and immunity: Special reference to major histocompatability complex // Emerging Infectious Diseases. — 1997. — № 3(1). — Р. 24-34.

Захарычева Т.А., Колотушкина Г.Б., Жукова С.Г., Сай И.А. Антигены системы HLA у больных различными формами клещевого энцефалита в хабаровском крае // Нейроиммунология. Юбилейная X конференция. 28–31 мая 2001 г. — Т. 2. — С. 223-97.

Poland G.A., Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., Schaid D.J. Identification of an association between HLA class II alleles and low antibody levels after measles immunization // Vaccine. — 2001. — № 20. — Р. 430-8.

Jacobson R.M., Poland G.A., Vierkant R.A., Pankratzd V., Schaidd D.J., Jacobsene S.J. et al. The association of class I HLA alleles and antibody levels following a single dose of measles vaccine // Hum. Immunol. — 2003. — № 64. — Р. 103-9.

Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Shane Pankratz V., Jacobsen S.J., Poland G.A. Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination // Vaccine. — 2004. — № 22. — Р. 1914-20.

Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Pankratz V.S., Poland G.A. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design // Vaccine. — 2007. — № 25. — Р. 3090-100.

Ovsyannikova I.G., Pankratz S.V., Vierkant R., Jacobson R.M., Poland G.A. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine // J. Infect. Dis. — 2006. — № 193. — Р. 655-63.

Ovsyannikova I.G., Jacobson R.M., Dhiman N., Vierkant R.A., Pankratz V.S., Poland G.A. Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine // Pediatrics. — 2008. — № 121. — Р. 1091-9.

Ovsyannikova I.G., Jacobson R.M., Ryan J.E. et al. Relationship between HLA polymorphisms and γ-interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination // Clin. Vaccine Immunol. — 2007. — № 14. — Р. 115-22.

Poland G.A., Ovsyannikova I.G., Jacobson R.M. Application of pharmacogenomics to vaccines // Pharmacogenomics. — 2009. — № 10(5). — Р. 837-52.

Poland G.A., Ovsyannikova I.G., Jacobson R.M. Immunogenetics of seasonal influenza vaccine response // Vaccine. — 2008. — № 26. — Р. 35-40.

Poland G.A., Ovsyannikova I.G., Jacobson R.M. Immunogenetics of seasonal influenza vaccine response // Vaccine. — 2008. — № 26. — Р. 6183-8.

Gelder C.M., Lambkin R., Hart K.W., Fleming D., Williams O.M., Bunce M. et al. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine // J. Infect. Dis. — 2002. — № 185. — Р. 114-7.

Ovsyannikova I.G., Jacobson R.M., Targonski P.V. et al. Vaccine Congress. Amsterdam: The Netherlands; 2007. Influence of host genetic variation on the immune response to the smallpox vaccine; p. 9-11. Abstract 033.

Willems A., Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved // Tissue Antigens. — 1998. — № 51(6). — Р. 593-604.

Poland G.A., Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., Schaid D.J. Identification of an association between HLA class II alleles and low antibody levels after measles immunization // Vaccine. — 2001. — № 20. — Р. 430-8.

Wang C., Tang J., Song W., Lobashevsky E., Wilson C.M., Kaslow R.A. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination // Hepatology. — 2004. — № 39(4). — Р. 978-88.

Thursz M. Pros and cons of genetic association studies in hepatitis B // Hepatology. — 2004. — № 40(2) — Р. 284-6.

Engele M., Stossel E., Castiglione K., Schwerdtner N., Wagner W., Bölcskei P. et al. Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis // J. Immunol. — 2002. — № 168. — Р. 1328-37.

Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J. et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis // J. Exp. Med. — 1995. — № 182. — Р. 1259-64.

Conway D.J., Holland M.J., Bailey R.L., Campbell A.E., Mahdi O.S.M., Jennings R. et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNFalpha levels in tear fluid // Infect. Immun. — 1997. — № 65. — Р. 1003-6.

McGuire W., Hill A., Allsopp C., Greenwood B.M., Kwiatkowski D. Variation in the TNF-a promoter region associated with susceptibility to cerebral malaria // Nature. — 1994. — № 371. — Р. 508-11.

Nadal D., Leppert D., Frei K., Gallo P., Lamche H., Fontana A. Tumour necrosis factor-alpha in infectious meningitis // Arch. Dis. Child. — 1989. — № 64. — Р. 1274-9.

Wilson A., Symons J., McDowell T., McDevitt H.O., Duff G.W. Effects of polymorphism in the tumor necrosis factor alpha promoter on transcriptional activation // Proc. Natl. Acad. Sci. USA. — 1997. — № 94(10). — Р. 3195-9.

Shaw M.A., Donaldson I.J., Collins A., Peacock C.S., Lins-Lainson Z., Shaw J.J. et al. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes // Genes. Immun. — 2001. — № 2. — Р. 196-204.

Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. Associations between cytokine/cytokine receptor SNPs and humoral immunity to measles, mumps and rubella in a Somali population // Tissue Antigens. — 2008. — № 72. — Р. 211-20.

Dhiman N., Ovsyannikova I.G., Cunningham J.M., Robert A. Vierkantc, V. Pankratzc S., Jacobson R.M. et al. Associations between measles vaccine immunity and single nucleotide polymorphisms in cytokine and cytokine receptor genes // J. Infect. Dis. — 2007. — № 195. — Р. 21-9.

Stanley S.L. Jr, Frey S.E., Taillon-Miller P., Guo J., Miller R.D., Koboldt D.C. et al. The immunogenetics of smallpox vaccination // J. Infect. Dis. — 2007. — № 196. — Р. 212-219.

Usonis V., Bakasenas V., Kaufhold A., Chitour K., Clemens R. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children // Pediatr. Infect. Dis. J. — 1999. — № 18. — Р. 42-48.

Vestergaard M., Hviid A., Madsen K.M., Wohlfahrt J., Thorsen P., Schendel D., Melbye M., Olsen J. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis // JAMA. — 2004. — № 292. — Р. 351-7.

Altare F., Lammas D., Revy P., Jouanguy E., Döffinger R., Lamhamedi S. et al. Inherited Interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated Infection // J. Clin. Invest. — 1998. — № 102(12). — Р. 2035-40.

Elloumi-Zghal H., Ridha Barbouche M., Chemli J., Bejaoui M., Harbi A., Snoussi N., Abdelhak S., Dellagi K. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis Bacille Calmette-Guerin infection // The Journal of Infectious Diseases. — 2002. — № 185. — Р. 1468-75.

Li-Hsin H., Shyh-Dar S., Jyh-Der W., Shin-Chi, Chin-Yuan T., Fu-Yuan H. Disseminated bacille Calmette-Guérin disease as the initial presentation of X-linked severe combined Immunode-ficiency. A case report // Asian Pacific Journal of Allergy and Immunology. — 2005. — № 23. — Р. 221-6.

Marquet S., Schurr E. Genetics of susceptibility to infectious diseases: tuberculosis and leprosy as examples // Drug Metabolism and Disposition. — 2001. — № 29(4). — Р. 478-83.

Jouanguy E., Lamhamedi-Cherradi S., Lammas D. et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection // Nat. Genet. — 1999. — № 21. — Р. 370-8.

Jouanguy E., Lamhamedi-Cherradi S., Altare F., Fondanèche M.C., Tuerlinckx D., Blanche S. et al. Partial interferon-γ receptor 1 deficiency in a child with tuberculoid Bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis // J. Clin. Invest. — 1997. — № 100(11). — Р. 2658-64.

Sasaki Y., Nomura A., Kusuhara K., Takada H., Ahmed S., Obinata K., Hamada K., Okimoto Y., Hara T. Genetic basis of patients with bacille Calmette-Guerin osteomyelitis in Japan: identification of dominant partial interferon-γ receptor 1 deficiency as a predominant type // J. Infect. Dis. — 2002. — № 185. — Р. 706-9.

Reif D.M., McKinney B.A., Motsinger A.A., Chanock S.J., Edwards K.M., Rock M.T., Moore J.H. et al. Genetic basis for adverse events after smallpox vaccination // J. Infect. Dis. — 2008. — № 198. — Р. 1-7.

Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. Associations between cytokine/cytokine receptor SNPs and humoral immunity to measles, mumps and rubella in a Somali population // Tissue Antigens. — 2008б — № 72. — Р. 211-20.

Dhiman N., Ovsyannikova I.G., Vierkant R.A. et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results // Vaccine. — 2008. — № 26. — Р. 1731-36.

Poland G.A., Ovsyannikova I.G., Jacobson R.M. Application of pharmacogenomics to vaccines // Pharmacogenomics. — 2009. — № 10(5). — Р. 837-52.

Ovsyannikova I.G., Haralambieva I.H., Vierkant R.A., O’Byrne M.M., Jacobson R.M., Poland G.A. Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine // Pharmacogenet Genomics. — 2012. — № 22(1). — Р. 20-31.

McNicholl J., Smith D.K., Qari S., Hodge T. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele // Emerging Infectious diseases. — 1997. — № 3(3). — Р. 261-72.

Bellamy R., Ruwende C., Corrah T., McAdam K.P.W.J., Thursz M., Whittle H.C., Hill A.V.S. Tuberculosis and chronic hepatitis B virus infection in africans and variation in the vitamin D receptor gene // The Journal of Infectious Diseases. — 1999. — № 179. — Р. 721-4.

Abel L., Vu D.L., Oberti J., Nguyen V.T., Van V.C., Guilloud-Bataille M., Schurr E., Lagrange P.H. et al. Complex segregation analysis of leprosy in southern Vietnam // Genet. Epidemiol. — 1995. — № 12. — Р. 63-82.

Malik S., Abel L., Tooker H., Poon A., Simkin L., Girard M. et al. Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease // Proc. Natl. Acad. Sci. USA. — 2005. — № 102(34). — Р. 12183-8.

Alm J., Sanjeevi C.B., Miller E.N., Dabadghao P., Lilja G., Pershagen G. et al. Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471 // Genes and Immunity. — 2002. — № 3. — Р. 71-7.

Hoal-Van H., Epstein J., Victor T., Hon D., Lewis L.A., Beyers N. et al. Mannosebinding protein B allele confers protection against tuberculous meningitis // Pediatr. Res. — 1999. — № 45(Pt. 1). — Р. 459-64.

Pöyhönen L., Kröger L., Gröndahl-Yli-Hannuksela K., Vuononvirta J., Huhtala H., He Q., Korppi M. Variant MBL2 genotypes producing low mannose-binding lectin may increase risk of Bacillus Calmette-Guerin osteitis in vaccinated newborns // Acta Paediatr. — 2013. — № 102(11). — Р. 1095-9.




DOI: https://doi.org/10.22141/2312-413x.1.06.2015.78529

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 ACTUAL INFECTOLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта